— Know what they know.
Not Investment Advice
Also trades as: 0IV3.L (LSE) · $vol 0M

GERN NASDAQ

Geron Corporation
1W: -7.3% 1M: -8.0% 3M: -17.9% YTD: -12.9% 1Y: -7.3% 3Y: -35.0% 5Y: -19.0%
$1.15
+0.00 (+0.00%)
 
Weekly Expected Move ±5.4%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 30 · $738.8M mcap · 556M float · 1.88% daily turnover · Short 52% of daily vol
Credit Risk of going bust: higher than 60% of companies Debt: 14.2% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.02 (down 98%), Geron Corporation would be worth roughly what it owes.
Total debt $122.1M against a stock market value of $738.8M.
Distance to default 4.22 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $60.1M (short-term plus half of long-term), stock volatility 62.8%; Altman Z'' -6.31. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
44.8 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: -74.1%  ·  5Y Avg: -204.5%
Cost Advantage
50
Intangibles
26
Switching Cost
53
Network Effect
78
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. GERN shows a Weak competitive edge (44.8/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Network Effects. Negative ROIC of -74.1% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 15Hold: 7Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$—
Analysts0
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2025-02-27 Barclays Peter Lawson Initiated $4 — +148.4% $1.61
2024-11-05 H.C. Wainwright Emily Bodnar Initiated $8 — +88.7% $4.24
2024-10-22 B.Riley Financial Kalpit Patel Initiated $6 — +39.2% $3.95
2024-09-09 Leerink Partners Faisal Khurshid Initiated $7 — +64.7% $4.25
2024-06-10 Goldman Sachs Corinne Jenkins $5 $6 +1 +21.3% $4.95
2024-06-10 Stifel Nicolaus Stephen Willey Initiated $7 — +52.5% $4.59
2024-04-29 Robert W. Baird Joel Beatty Initiated $4 — +8.7% $4.14
2024-03-15 Needham Gil Blum $4 $5 +1 +48.8% $3.36
2024-03-14 Goldman Sachs Corinne Jenkins Initiated $5 — +48.8% $3.36
2023-01-09 Needham — Initiated $4 — +43.6% $2.79
2023-01-04 Wedbush — Initiated $6 — +90.5% $3.15

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
Oct 27, 2026
DCF
1
ROE
1
ROA
1
D/E
2
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. GERN receives an overall rating of C-. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-10-26 D+ C-
2026-10-01 C- D+
2026-08-06 D+ C-
2026-05-11 C- D+
2026-05-06 D+ C-
2026-02-26 C- D+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 34 Grade D
Profitability
20
Balance Sheet
60
Earnings Quality
41
Growth
84
Value
36
Momentum
77
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. GERN scores highest in Growth (84/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-2.26
Distress Zone
Piotroski F-Score
2/9
✗ ✗ ✓ ✗ ✗ ✗ ✗ ✗ ✓
Beneish M-Score
-1.81
Unlikely Manipulator
Ohlson O-Score
-5.89
Bankruptcy prob: 0.3%
Low Risk
Credit Rating
B
Score: 29.8/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: 1.64x
Accruals: 8.3%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. GERN scores -2.26, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. GERN scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. GERN's score of -1.81 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. GERN's implied 0.3% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. GERN receives an estimated rating of B (score: 29.8/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-11.53x
PEG
-0.53x
P/S
3.61x
P/B
3.53x
P/FCF
-7.48x
P/OCF
—
EV/EBITDA
-16.36x
EV/Revenue
3.32x
EV/EBIT
-15.95x
EV/FCF
-5.92x
Earnings Yield
-8.14%
FCF Yield
-13.37%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. GERN currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.640
EBT / EBIT
×
EBIT Margin
-0.208
EBIT / Rev
×
Asset Turnover
0.381
Rev / Assets
×
Equity Multiplier
2.247
Assets / Equity
=
ROE
-29.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. GERN's ROE of -29.2% is driven by Asset Turnover (0.381), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$1.15
Median 1Y
$0.86
5th Pctile
$0.28
95th Pctile
$2.69
Ann. Volatility
72.6%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Harout Semerjian (as
sident and Chief Executive Officer (as of August 7, 2025)
$321,538 $— $10,221,755
John A. Scarlett,
M.D. Former Chairman of the Board, President and Chief Executive Officer
$309,781 $1,078,300 $7,422,754
Andrew J. Grethlein,
Ph.D. Former Executive Vice President, Chief Operating Officer
$563,276 $368,200 $3,316,444
Ahmed ElNawawi President,
Vice President, Chief Commercial Officer (as of October 20, 2025)
$107,692 $— $2,881,334
James Ziegler President,
cutive Vice President, Chief Commercial Officer (as of September 9, 2024)
$470,028 $234,070 $2,392,709
Michelle J. Robertson
Executive Vice President, Finance, Chief Financial Officer, Treasurer and Interim Secretary
$559,800 $289,300 $2,250,082
Joseph Eid, M.D.
Executive Vice President, Research & Development, Chief Medical Officer (as of November 11, 2024)
$650,000 $— $1,001,052
Dawn C. Bir
Former Interim President and Chief Executive Officer (as of March 17, 2025)
$318,190 $— $522,122

CEO Pay Ratio

17:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $10,221,755
Avg Employee Cost (SGA/emp): $617,271
Employees: 258

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
258
+12.7% YoY
Revenue / Employee
$712,717
Rev: $183,881,000
Profit / Employee
$-332,488
NI: $-85,782,000
SGA / Employee
$617,271
Avg labor cost proxy
R&D / Employee
$285,717
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -56.1% -68.8% -79.3% -73.5% -1.0% -1.4% -70.8% -77.7% -87.7% -1.1% -60.0% -72.6% -69.0% -66.1% -45.3% -31.1% -29.6% -33.9% -28.0% -29.2% -29.24%
ROA -41.9% -46.7% -51.8% -47.7% -56.9% -68.1% -48.1% -52.3% -54.1% -63.0% -44.4% -50.8% -46.9% -35.3% -26.6% -17.5% -15.8% -14.7% -12.7% -13.0% -13.01%
ROIC -5.6% 39.0% 6.5% 4.1% 3.2% 3.0% -102.5% 8.1% -4.3% -1028.3% 14.2% -5.8% -4.1% 30.3% 15.5% 9.3% 5.0% -36.2% -17.7% -74.1% -74.05%
ROCE -55.8% -63.2% -75.2% -58.5% -79.5% -1.2% -38.0% -48.2% -54.1% -61.5% -53.4% -60.3% -61.6% -30.9% -23.2% -12.1% -9.6% -11.6% -8.2% -9.5% -9.50%
Gross Margin -169.0% -21.1% -178.7% 1.0% -81.8% -260.7% 1.0% 1.0% 1.0% 1.0% 1.0% 98.1% 98.4% 98.4% 97.0% 97.6% 53.2% 97.3% 96.7% 83.9% 83.92%
Operating Margin -235.5% -29.8% -233.1% -383.2% -134.5% -407.3% -1909.1% -1791.4% -290.3% -2360.4% -184.7% -78.6% -99.8% -42.2% -42.2% -25.4% -29.4% -22.5% -0.5% -21.7% -21.74%
Net Margin -244.9% -30.8% -244.7% -385.2% -138.2% -413.9% -1815.3% -1697.5% -273.2% -2259.7% -182.2% -76.4% -93.5% -53.3% -50.1% -33.4% -39.0% -64.9% -7.0% -29.0% -29.02%
EBITDA Margin -235.1% -29.7% -232.7% -360.5% -110.7% -474.5% -1711.9% -1618.9% -259.0% -2148.3% -170.0% -72.1% -82.1% -34.4% -28.6% -15.4% -20.4% -49.1% 7.4% -21.1% -21.15%
FCF Margin -213.7% -68.7% -70.4% -80.3% -74.9% -214.4% -284.5% -314.7% -513.9% -711.3% -355.2% -151.9% -7.3% -2.8% -1.8% -1.1% -72.4% -60.4% -64.4% -56.1% -56.12%
OCF Margin -213.4% -68.6% -70.2% -80.0% -74.6% -213.7% -282.9% -312.7% -511.0% -707.8% -353.1% -151.1% -7.3% -2.8% -1.8% -1.1% -72.5% -60.4% -64.2% -55.9% -55.91%
ROE 3Y Avg snapshot only -45.82%
ROE 5Y Avg snapshot only -55.42%
ROA 3Y Avg snapshot only -26.06%
ROIC 3Y Avg snapshot only -1.80%
ROIC Economic snapshot only -8.78%
Cash ROA snapshot only -22.04%
Cash ROIC snapshot only -2.87%
CROIC snapshot only -2.88%
NOPAT Margin snapshot only -14.45%
Pretax Margin snapshot only -34.17%
R&D / Revenue snapshot only 36.12%
SGA / Revenue snapshot only 75.75%
SBC / Revenue snapshot only 11.76%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -4.18 -3.48 -3.81 -5.35 -7.22 -6.96 -7.88 -10.27 -7.03 -6.82 -9.89 -12.63 -14.94 -13.10 -7.62 -10.67 -11.43 -10.27 -14.33 -12.28 -11.535
P/S Ratio 1118.21 289.75 327.49 465.42 618.56 1657.23 2391.65 3903.94 3875.58 5297.06 3829.86 2019.34 101.97 29.70 9.10 5.71 4.98 4.79 5.09 4.20 3.612
P/B Ratio 2.97 3.19 4.63 4.41 8.77 12.35 3.62 5.89 4.23 5.06 5.77 9.04 10.29 8.16 3.95 3.62 3.67 3.90 4.35 3.93 3.528
P/FCF -5.23 -4.21 -4.65 -5.80 -8.26 -7.73 -8.41 -12.41 -7.54 -7.45 -10.78 -13.29 -13.89 -10.43 -5.18 -5.27 -6.88 -7.93 -7.90 -7.48 -7.479
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA -2.96 -2.42 -2.98 -4.14 -6.81 -6.37 -5.95 -8.75 -5.57 -5.76 -8.58 -12.05 -14.65 -12.93 -6.84 -11.53 -14.61 -14.82 -25.30 -16.36 -16.360
EV/Revenue 779.47 197.34 246.67 343.51 527.70 1460.93 1733.96 3202.94 3063.25 4251.49 3144.25 1818.55 93.41 26.00 6.74 4.09 3.57 4.20 4.77 3.32 3.323
EV/EBIT -2.96 -2.41 -2.98 -4.13 -6.79 -6.35 -5.92 -8.72 -5.55 -5.73 -8.53 -11.98 -14.56 -12.83 -6.77 -11.31 -14.27 -14.54 -24.61 -15.95 -15.953
EV/FCF -3.65 -2.87 -3.51 -4.28 -7.05 -6.81 -6.10 -10.18 -5.96 -5.98 -8.85 -11.97 -12.72 -9.13 -3.83 -3.78 -4.93 -6.95 -7.40 -5.92 -5.922
Earnings Yield -23.9% -28.8% -26.2% -18.7% -13.8% -14.4% -12.7% -9.7% -14.2% -14.7% -10.1% -7.9% -6.7% -7.6% -13.1% -9.4% -8.8% -9.7% -7.0% -8.1% -8.14%
FCF Yield -19.1% -23.7% -21.5% -17.2% -12.1% -12.9% -11.9% -8.1% -13.3% -13.4% -9.3% -7.5% -7.2% -9.6% -19.3% -19.0% -14.5% -12.6% -12.7% -13.4% -13.37%
Price/Tangible Book snapshot only 3.927
EV/Gross Profit snapshot only 3.994
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 4.66 4.11 3.77 4.85 2.68 2.35 8.81 5.20 3.75 3.16 3.67 3.61 2.89 5.56 7.87 7.87 5.96 4.66 6.78 6.92 6.915
Quick Ratio 4.66 4.11 3.77 4.85 2.68 2.35 8.81 5.20 3.75 3.16 3.67 3.60 2.74 5.12 6.97 6.79 4.87 4.66 6.78 5.16 5.158
Debt/Equity 0.26 0.44 0.57 0.39 0.51 0.70 0.17 0.19 0.19 0.35 0.25 0.28 0.30 0.43 0.45 0.47 0.49 1.11 1.10 0.56 0.559
Net Debt/Equity -0.90 -1.02 -1.14 -1.15 -1.29 -1.46 -1.00 -1.06 -0.89 -1.00 -1.03 -0.90 -0.86 -1.02 -1.03 -1.03 -1.04 -0.48 -0.27 -0.82 -0.817
Debt/Assets 0.17 0.24 0.28 0.23 0.24 0.29 0.13 0.13 0.14 0.22 0.18 0.19 0.20 0.20 0.22 0.22 0.21 0.44 0.47 0.24 0.235
Debt/EBITDA -0.38 -0.48 -0.48 -0.50 -0.47 -0.41 -0.39 -0.34 -0.32 -0.49 -0.45 -0.42 -0.46 -0.79 -1.06 -2.09 -2.72 -4.83 -6.82 -2.94 -2.940
Net Debt/EBITDA 1.29 1.13 0.98 1.47 1.17 0.86 2.26 1.92 1.48 1.42 1.87 1.33 1.34 1.84 2.40 4.56 5.76 2.08 1.69 4.30 4.301
Interest Coverage -31.82 -30.48 -25.52 -21.30 -19.82 -19.92 -19.75 -21.34 -21.90 -21.15 -19.50 -18.71 -15.60 -8.43 -4.97 -2.09 -1.35 -1.63 -1.20 -1.41 -1.409
Equity Multiplier 1.51 1.79 2.04 1.68 2.15 2.38 1.30 1.39 1.42 1.59 1.40 1.47 1.52 2.12 2.10 2.14 2.28 2.53 2.33 2.37 2.374
Cash Ratio snapshot only 4.278
Debt Service Coverage snapshot only -1.374
Cash to Debt snapshot only 2.463
FCF to Debt snapshot only -0.940
Defensive Interval snapshot only 623.0 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.00 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.16 0.22 0.33 0.36 0.32 0.36 0.38 0.381
Inventory Turnover — — — — — — — — — — — 0.04 0.05 0.06 0.09 0.10 0.44 1.33 0.94 0.36 0.356
Receivables Turnover 0.50 1.12 — 0.63 5.03 0.24 — 0.21 — 0.10 0.64 3.14 2.11 4.10 7.09 8.77 5.79 5.04 5.37 4.64 4.636
Payables Turnover 18.07 12.43 15.98 15.36 10.80 8.73 10.71 8.46 2.47 0.00 0.00 0.00 0.03 0.17 0.27 0.53 2.04 2.60 2.53 4.03 4.034
DSO 724 326 0 577 73 1503 0 1725 0 3695 572 116 173 89 51 42 63 72 68 79 78.7 days
DIO 0 0 0 0 0 0 0 0 0 — — 8309 7826 5625 4168 3509 835 274 390 1024 1023.9 days
DPO 20 29 23 24 34 42 34 43 148 — — 142704 10579 2144 1336 695 179 140 144 90 90.5 days
Cash Conversion Cycle 704 296 -23 553 39 1461 -34 1682 -148 — — -134279 -2580 3570 2883 2856 719 206 314 1012 1012.2 days
Fixed Asset Turnover snapshot only 71.725
Operating Cycle snapshot only 1102.7 days
Cash Velocity snapshot only 0.680
Capital Intensity snapshot only 2.537
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 7.8% 4.5% 3.1% 2.3% 2.8% -57.2% -64.2% -66.5% -79.3% -60.2% 5.3% 2.1% 92.0% 323.9% 222.6% 118.8% 5.2% 1.4% 68.6% 24.4% 24.39%
Net Income -33.4% -53.6% -35.9% -16.0% -21.7% -22.2% -26.6% -46.3% -33.1% -29.8% -34.3% -28.4% -15.1% 5.2% 31.0% 59.9% 60.2% 50.9% 49.9% 20.6% 20.58%
EPS -29.2% -48.0% -32.5% 6.1% 1.2% 0.9% 22.8% -7.9% 6.9% 11.0% -21.2% -7.4% -0.7% 12.7% 37.4% 60.7% 60.5% 52.4% 50.2% 21.1% 21.12%
FCF -32.7% -42.8% -32.2% -37.3% -33.3% -33.5% -44.8% -31.2% -41.9% -31.9% -31.4% -47.3% -32.9% -30.1% -10.7% 14.5% 38.6% 49.3% 38.2% 35.6% 35.61%
EBITDA -27.7% -49.1% -29.7% -11.5% -11.9% -20.1% -26.3% -47.7% -46.8% -27.9% -32.3% -25.9% -7.9% 11.4% 39.9% 71.8% 76.1% 66.4% 67.7% 28.9% 28.86%
Op. Income -27.0% -48.2% -29.1% -12.6% -20.0% -21.5% -31.3% -53.5% -42.3% -40.0% -40.0% -30.7% -14.5% 10.4% 36.0% 65.9% 69.7% 69.0% 72.2% 51.7% 51.68%
OCF Growth snapshot only 35.85%
Asset Growth snapshot only -6.52%
Equity Growth snapshot only -15.77%
Debt Growth snapshot only 0.25%
Shares Change snapshot only 0.68%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y -23.0% 9.3% 19.7% 24.4% 32.2% 9.0% 2.8% 4.3% -5.4% -2.2% 15.4% 50.6% 3.2% 2.8% 3.4% 4.0% 3.9% 5.8% 6.3% 6.7% 6.69%
Revenue 5Y -42.3% -25.7% -25.4% -25.6% 9.6% -11.0% -10.2% -12.6% -18.5% -26.0% -8.4% 14.5% 1.1% 1.8% 2.0% 2.3% 2.5% 2.7% 2.6% 2.5% 2.48%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 5Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y 6.8% 6.9% 4.1% 12.7% 12.3% 4.8% 43.8% 14.8% 13.1% 13.3% 23.1% 21.2% 24.8% 38.0% 41.5% 32.6% 34.6% 44.1% 7.9% 7.7% 7.71%
Assets 5Y 11.0% 11.7% 9.0% 13.9% 15.3% 11.6% 32.1% 17.8% 17.1% 16.3% 22.4% 22.0% 22.1% 29.1% 31.5% 15.1% 14.7% 16.1% 15.6% 15.5% 15.53%
Equity 3Y -6.2% -10.7% -16.8% -3.3% -10.8% -16.0% 39.2% 6.0% 7.7% 5.5% 19.7% 20.3% 24.5% 30.4% 40.1% 22.3% 32.0% 41.3% -11.1% -9.9% -9.85%
Book Value 3Y -22.6% -26.3% -31.4% -25.2% -30.8% -34.0% -0.3% -18.7% -11.8% -14.3% -2.8% -4.5% -1.4% 4.3% 11.1% 3.5% 11.8% 20.0% -17.0% -15.8% -15.76%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.73 0.61 0.57 0.56 0.03 0.01 0.00 0.00 0.00 0.18 0.03 0.18 0.41 0.41 0.41 0.41 0.51 0.64 0.68 0.68 0.683
Earnings Stability 0.82 0.84 0.89 0.93 0.95 0.95 0.97 0.96 0.99 0.98 0.97 0.97 0.99 0.93 0.65 0.20 0.12 0.10 0.00 0.03 0.033
Margin Stability 0.00 0.07 0.09 0.09 0.10 0.40 0.40 0.34 0.21 0.04 0.08 0.09 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.50 0.50 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.87 0.50 0.86 0.94 0.91 0.91 0.89 0.81 0.87 0.88 0.86 0.89 0.94 0.98 0.88 0.50 0.50 0.50 0.80 0.92 0.918
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend -0.38 -0.49 -0.69 -0.38 -0.68 -1.14 0.36 0.12 0.36 0.60 0.25 -0.02 0.22 0.64 0.00 0.31 0.32 0.30 0.25 0.21 0.208
Gross Margin Trend -111.75 56.85 64.29 91.06 104.93 -29.47 -4.21 -19.00 32.43 92.13 83.19 80.91 65.22 61.78 52.16 57.27 42.39 -0.13 -0.12 -0.15 -0.151
FCF Margin Trend -99.23 111.86 101.79 95.22 118.73 -47.56 -140.68 -176.77 -369.58 -569.68 -177.78 45.56 287.01 460.01 318.07 232.22 259.88 356.46 177.83 75.94 75.940
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.80 0.82 0.82 0.92 0.87 0.90 0.93 0.82 0.93 0.91 0.91 0.95 1.07 1.25 1.47 2.03 1.66 1.29 1.81 1.64 1.636
FCF/OCF 1.00 1.00 1.00 1.00 1.00 1.00 1.01 1.01 1.01 1.00 1.01 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.004
FCF/Net Income snapshot only 1.642
CapEx/Revenue 28.5% 14.9% 17.9% 23.6% 25.7% 72.3% 1.5% 2.0% 2.9% 3.5% 2.1% 78.4% 3.0% 0.9% 0.1% 0.0% 0.1% 0.0% 0.2% 0.2% 0.20%
CapEx/Depreciation snapshot only 0.394
Accruals Ratio -0.08 -0.08 -0.09 -0.04 -0.07 -0.07 -0.03 -0.09 -0.04 -0.06 -0.04 -0.03 0.03 0.09 0.13 0.18 0.10 0.04 0.10 0.08 0.083
Sloan Accruals snapshot only -0.049
Cash Flow Adequacy snapshot only -273.627
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -4.2% -5.7% -1.5% -11.8% -8.3% -8.8% -25.4% -14.1% -22.2% -21.1% -9.7% -6.3% -4.9% -6.3% -0.3% -0.5% -0.2% -0.2% -0.4% -0.6% -0.55%
Total Shareholder Return -4.2% -5.7% -1.5% -11.8% -8.3% -8.8% -25.4% -14.1% -22.2% -21.1% -9.7% -6.3% -4.9% -6.3% -0.3% -0.5% -0.2% -0.2% -0.4% -0.6% -0.55%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.02 1.02 1.04 1.05 1.10 1.03 1.04 1.03 1.00 1.05 1.05 1.05 1.06 1.12 1.20 1.48 1.74 1.61 1.83 1.64 1.640
EBIT Margin -263.73 -81.84 -82.83 -83.17 -77.72 -230.05 -292.78 -367.38 -552.41 -741.84 -368.41 -151.79 -6.41 -2.03 -1.00 -0.36 -0.25 -0.29 -0.19 -0.21 -0.208
Asset Turnover 0.00 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.16 0.22 0.33 0.36 0.32 0.36 0.38 0.381
Equity Multiplier 1.34 1.47 1.53 1.54 1.78 2.02 1.47 1.48 1.62 1.78 1.35 1.43 1.47 1.87 1.70 1.77 1.87 2.30 2.20 2.25 2.247
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-0.33 $-0.35 $-0.36 $-0.29 $-0.32 $-0.35 $-0.28 $-0.31 $-0.30 $-0.31 $-0.33 $-0.34 $-0.30 $-0.27 $-0.21 $-0.13 $-0.12 $-0.13 $-0.10 $-0.10 $-0.10
Book Value/Share $0.46 $0.38 $0.29 $0.35 $0.27 $0.20 $0.60 $0.55 $0.50 $0.42 $0.57 $0.47 $0.44 $0.43 $0.40 $0.39 $0.37 $0.34 $0.34 $0.33 $0.33
Tangible Book/Share $0.46 $0.38 $0.29 $0.35 $0.27 $0.20 $0.60 $0.55 $0.50 $0.42 $0.57 $0.47 $0.44 $0.43 $0.40 $0.39 $0.37 $0.34 $0.34 $0.33 $0.33
Revenue/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.04 $0.12 $0.17 $0.25 $0.27 $0.28 $0.29 $0.30 $0.30
FCF/Share $-0.26 $-0.29 $-0.29 $-0.27 $-0.28 $-0.31 $-0.26 $-0.26 $-0.28 $-0.28 $-0.31 $-0.32 $-0.33 $-0.34 $-0.31 $-0.27 $-0.20 $-0.17 $-0.19 $-0.17 $-0.17
OCF/Share $-0.26 $-0.29 $-0.29 $-0.27 $-0.28 $-0.31 $-0.26 $-0.26 $-0.28 $-0.28 $-0.30 $-0.32 $-0.33 $-0.34 $-0.31 $-0.27 $-0.20 $-0.17 $-0.19 $-0.17 $-0.17
Cash/Share $0.54 $0.56 $0.50 $0.54 $0.48 $0.42 $0.70 $0.68 $0.54 $0.56 $0.73 $0.55 $0.51 $0.63 $0.60 $0.58 $0.57 $0.54 $0.47 $0.45 $0.45
EBITDA/Share $-0.32 $-0.34 $-0.34 $-0.28 $-0.29 $-0.33 $-0.26 $-0.30 $-0.30 $-0.29 $-0.32 $-0.32 $-0.28 $-0.24 $-0.17 $-0.09 $-0.07 $-0.08 $-0.06 $-0.06 $-0.06
Debt/Share $0.12 $0.17 $0.17 $0.14 $0.14 $0.14 $0.10 $0.10 $0.10 $0.14 $0.14 $0.13 $0.13 $0.19 $0.18 $0.18 $0.18 $0.38 $0.38 $0.18 $0.18
Net Debt/Share $-0.42 $-0.39 $-0.34 $-0.41 $-0.34 $-0.29 $-0.60 $-0.58 $-0.44 $-0.42 $-0.59 $-0.42 $-0.38 $-0.44 $-0.41 $-0.40 $-0.39 $-0.16 $-0.09 $-0.27 $-0.27
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -2.261
Altman Z-Prime snapshot only -4.077
Piotroski F-Score 2 3 2 3 3 1 5 3 5 5 1 2 1 4 3 3 3 2 2 2 2
Beneish M-Score -3.84 20.75 -3.42 -111.66 -1.89 7.07 -99.83 -3.99 -44.50 -139.37 9.43 24.23 150.56 1840.11 113.29 46.31 -1.23 -2.46 -1.85 -1.81 -1.815
Ohlson O-Score snapshot only -5.891
ROIC (Greenblatt) snapshot only -10.17%
Net-Net WC snapshot only $0.28
EVA snapshot only $-33544010.00
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only B
Credit Score 28.94 29.30 28.46 30.78 29.11 28.28 49.69 61.49 38.90 31.88 57.56 63.70 62.75 36.61 31.33 31.58 31.34 27.69 28.10 29.79 29.787
Credit Grade snapshot only 15
Credit Trend snapshot only -1.797
Implied Spread (bps) snapshot only 750.000
Industry Credit Rank snapshot only 21
Sector Credit Rank snapshot only 20

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms